Navigation Links
Enobia Pharma Raises $40.1 Million Series B Financing
Date:9/11/2007

MONTREAL and QUEBEC, Sept. 11 /PRNewswire/ -- Enobia Pharma Inc, announced today that it raised $Cdn 40.1 Million in a Series B multi-tranche financing. The proceeds will be used primarily to fund the Company's novel hypophosphatasia drug development program through Phase 2 clinical trials. There is no known cure for hypophosphatasia, a severe genetic disorder that affects the ability to mineralize bone.

The financing was co-led by new investors OrbiMed Advisors LLC ("OrbiMed") of New York and CTI Life Sciences Fund of Montreal ("CTI"). The Fonds de solidarite FTQ, Desjardins Venture Capital, Lothian Partners and T2C2/Bio 2000, current investors in the Company, also participated in the round.

Robert Heft, PhD, President and CEO of Enobia said, "With no drug therapy available, hypophosphatasia patients and their families experience prolonged and significant suffering. We are pleased that we were able to attract such world class investors to our company at this important time in our development. We are confident that with their support, we will build on our promising preclinical results to advance the clinical development program of an enzyme replacement therapy for hypophosphatasia."

Jonathan Silverstein, General Partner of OrbiMed said, "We are delighted to be associated with this impressive team working on such a debilitating disease for which there is no cure."

Richard Meadows, Managing Partner of CTI said, "This represents an example of the type of high quality investment opportunity that exists in Quebec and that is capable of attracting the attention and significant investment from our U.S. VC colleagues."

Both Mr. Silverstein and Mr. Meadows will join the newly constituted Board, which also includes: Robert Heft, who previously served on the Board; Fredric Price, also a former Board member, and an investor in this Series B financing who was previously Chairman & CEO of BioMarin Pharmaceutical and Thomas Schuetz, MD, PhD, wh
'/>"/>

SOURCE Enobia Pharma Inc
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
2. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
3. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
4. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
5. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
6. Germantown drug company hires pharma veteran James Davidson as COO
7. Deltanoid Pharmaceuticals begins phase II osteoporosis study
8. New angel capital centered on GenTel agreement with big pharma
9. The deconstruction of Big Pharma
10. Big pharma seeks Wisconsin biotech partnerships
11. Doing the pharmaceutical tango

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... , BEIJING, Nov. 25 /PRNewswire-A...eloper and provider of vaccines, announced today t...establish Sinovac (Dalian) Vaccine,Technology Co.,...lop, produce,and commercialize human-use vaccines....nce in developing and commercializing world-class ...
(Date:11/24/2009)... Ambassador to also Visit De...24, 2009 -- , , ,Who: David Appia, French Ambassad...CEO of the Invest in France Agency, , , , ,What: ...o discuss recent pro-business initiatives adopted ... and academic landscape for innovation and develop...
(Date:11/24/2009)... , ST. LOUIS, Nov. 24 /PRNewswire-FirstCa...will be presenting at the NASDAQ OMX conference on...:45 AM US/CST. Interested parties may listen via l... http://inve s tor.sig m a a ldrich.com/ ...is file. ,, About Sigma-Aldrich: Sigma-Al...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-As...e Food & Drug Administration (SFDA) has approv...for its oral insulin project,(Nodlin), an innovati...,approval allows Biolaxy to initiate its first pha...rder characteristic of high blood glucose and poor...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Biolaxy Secures IND Approval for Oral Insulin 2
...What kind of school systems are our taxes supporti...he fact that jobs are being outsourced to other co...c schools have lost touch with whats important. Ed...hing real skills along with the ability to learn a...bs comes from J.P. Morgan (which now includes Bank...
... There are few better ways to promote your busine...ing them on your web site. , ,Good content attract...f all American adults are on the Internet, accordi.... While online, the most popular activities inclu... engines. This means that if youve got good conten...
...Three Wisconsin chief information officers made th... They were: , , Carlton Harper, CIO of Modine Man...thermal management systems such as cooling for a n...ooled Jeep, and has been active in fuel-cell devel...nd CIO of ShopKo Stores Inc. , in Green Bay. Shop...
Other Biology Technology:With flawed schools exposed, real-world experience is needed 2With flawed schools exposed, real-world experience is needed 3With flawed schools exposed, real-world experience is needed 4The write stuff: marketing with articles 2The write stuff: marketing with articles 3The write stuff: marketing with articles 4
(Date:11/26/2009)...t worked out a way of using recordings of birdsong...s. This is the first time sound recordings from a ...e estimates of bird species, populations. Because ...cal Society,s Journal of Applied Ecology , will a... advance in our ability to monitor whale and dolph...
(Date:11/26/2009)...mber 26, 2009) Whitehead researchers have develop... pinpoint specific genes and proteins used by path...In most human cell cultures genes are present in t...rom the mother. Gene inactivation by mutation is t...tivated, the second copy usually remains active an...
(Date:11/26/2009)...stant Staphylococcus Aureus ) and other drug-resi...erature plasma prototype devices have been develop...icidal cocktails. , Two prototype devices have b...ealthy skin (e.g. hands and feet) in hospitals and...reat; and another to shoot bacteria-killing agents...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2Knockouts in human cells point to pathogenic targets 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Farmers Insurance Annual Challenge 3A Be a Hero for Babies Day 28SM 29 50795 1Farmers Insurance Annual Challenge 3A Be a Hero for Babies Day 28SM 29 50795 2Farmers Insurance Annual Challenge 3A Be a Hero for Babies Day 28SM 29 50795 3The Leukemia 26 Lymphoma Society and The International Waldenstroms Macroglobulinemia Foundation Partner to Develop Cell Lines to Advance Research 12902 1The Leukemia 26 Lymphoma Society and The International Waldenstroms Macroglobulinemia Foundation Partner to Develop Cell Lines to Advance Research 12902 2The Leukemia 26 Lymphoma Society and The International Waldenstroms Macroglobulinemia Foundation Partner to Develop Cell Lines to Advance Research 12902 3Dogs humans put heads together to find cure for brain cancer 9117 1Dogs humans put heads together to find cure for brain cancer 9117 2Dogs humans put heads together to find cure for brain cancer 9117 3
...wn speeding vehicles as the movie Jurassic Park wo...arnivore was certainly no slouch, research out tod... used a powerful supercomputer to calculate the ru...ried in size from a 3kg Compsognathus to a six-ton... most accurate ever produced puts the T. rex at s...
..., elephantnose fish (Gnathonemus petersii), finds ...cientists from the University of Bonn have now bee...rkness the animals can even distinguish the materi... living ones. The results have now been published ...h, which is as long as a cigar, hovers with its he...
...ree known domains of life -- eukaryotes, bacteria,...te ways around three billion years ago. But pinnin...task. , Now, a team of scientists present direct ...at least as long as 2.7 billion years ago. , The ...samples, loaded with oily lipid remains of archaea...
Other Biology News:T. rex quicker than Becks, say scientists 2Elephantnose fish 'see' with their chin 2Elephantnose fish 'see' with their chin 3Ancient organisms discovered in Canadian gold mine 2
Sheep Growth Hormone from Cell Sciences
Essential Techniques: Antibody Production from Promega
ELF® 97 Immunohistochemistry Kit from Molecular Probes (Invitrogen)
Dynabeads Epithelial Enrich from Dynal Biotech
Biology Products: